New syringe design tested for safety in common eye conditions
Disease control
Ongoing
This study tests whether a pre-filled syringe is as safe as the traditional vial for delivering an eye injection (bevacizumab) to treat wet age-related macular degeneration, diabetic macular edema, and branch retinal vein occlusion. About 120 participants will receive the injecti…
Phase: PHASE3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC